Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab + Ipilimumab vs Pazopanib in Rare Sarcomas
NCT04741438Phase 3Unknown
- Sponsor
- Centre Léon Bérard
- Start
- Mar 2021
- Primary completion
- Feb 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of nivolumab, ipilimumab in sarcoma, sponsored by Centre Léon Bérard. Status: unknown.
02
Drugs
nivolumabipilimumab
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT04741438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04741438.